Processa Pharmaceuticals, Inc. (PCSA): Operating Income
-$13.99M
Year ended 2025-12-31
-$12.86M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$13.99M | n/m | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | -$12.05M | n/m | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | -$11.46M | n/m | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | -$27.53M | n/m | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | -$12.13M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$15.14M | n/m | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | -$3.94M | n/m | 2021-03-25, From 2019-01-01 |
| 2018-12-31 | -$4.52M | n/m | 2020-03-06, From 2018-01-01 |
| 2017-12-31 | -$1.80M | n/m | 2019-04-08, From 2017-01-01 |
| 2016-12-31 | -$1.92M | n/a | 2018-04-16, From 2016-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | 2025-12-31 | -$13.99M | n/m |
| Dermata Therapeutics, Inc. (DRMA) | 2025-12-31 | -$7.77M | n/m |
| Acurx Pharmaceuticals, Inc. (ACXP) | 2025-12-31 | -$8.09M | n/m |
| Silo Pharma, Inc. (SILO) | 2025-12-31 | -$4.28M | n/m |
| Rocket One Inc. (RKTO) | 2025-12-31 | -$12.36M | n/m |
| Oncolytics Biotech Inc (ONCY) | 2025-12-31 | -$28.73M | n/m |
| GT Biopharma, Inc. (GTBP) | 2025-12-31 | -$12.42M | n/m |
| Ensysce Biosciences, Inc. (ENSC) | 2025-12-31 | -$10.24M | n/m |
| Xenetic Biosciences, Inc. (XBIO) | 2025-12-31 | -$2.83M | n/m |
Compare PCSA, DRMA, ACXP, SILO side by side · Screen every company in Pharmaceutical Preparations ↗